Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value - Wikidata - awgldk - TriplyDB

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

http://www.wikidata.org/entity/Q24806041

about

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4 Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement The role and clinical implications of G6PI in experimental models of rheumatoid arthritis Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis.Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis.Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritis Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis Structural basis for Ca(2+)-induced activation of human PAD4 Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis.Roles of B cells in rheumatoid arthritis Probing the Roles of Calcium-Binding Sites during the Folding of Human Peptidylarginine Deiminase 4.Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generatio Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4).Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis.Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening.Functional roles of the non-catalytic calcium-binding sites in the N-terminal domain of human peptidylarginine deiminase 4 Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.Juvenile onset central nervous system folate deficiency and rheumatoid arthritis.Protein microarrays: a new tool for the study of autoantibodies in immunodeficiency Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis.Clinical utility of the anti-CCP assay in patients with rheumatic diseases.Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: A meta-analysis.Chemical biology of protein arginine modifications in epigenetic regulation HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis pati Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity.Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis.

P2860

Q21195679-E6367273-346E-4FAE-9F32-E2831DAB12AD Q24310773-D3C67577-CBEE-47B9-9F7F-5351334AD31C Q24675281-92AE27DA-CDB2-48FB-8966-8A7936F5DF09 Q24676878-00D5031A-4B2C-43AC-B922-07C5AE39B308 Q24793557-0F911688-9366-43D3-87CD-C3B2FE96F9ED Q24799403-A80F0A52-5077-4921-8942-7D6EF662E5AE Q24810942-225AF648-E790-4F46-B3B0-CE9D4ABF5AF5 Q24812290-7F80EE5F-4EB5-4D39-8D0D-50A9BA6ECD39 Q24816615-DD69854C-07DE-496F-A016-CA98370B7C57 Q24816803-D7001E67-9537-42C2-85E5-F0ACCF382B36 Q26745541-809ADE98-BA4B-4953-81E1-DC27F9A403CA Q26991453-38D41958-B30D-43BF-B61C-FF4F64158603 Q26991867-67B08A7B-547F-49F6-B327-CB4EA06C8CF5 Q28271512-03AF24FD-9028-4BDE-8102-3CC364042284 Q33264597-C0EFCF6B-A330-4FA2-B9DF-AE1DE0D62C4A Q33322989-46389670-C32B-4AD7-9EF6-6B231BA187F0 Q33419722-B9A90652-0021-45C9-B3BA-476ECF2B93EA Q33708839-AB00E59E-AFFE-4D5E-857E-AAA9F147EFC8 Q33729177-FD713B2E-F167-4C20-8556-6D0D4EBC38D4 Q33849849-E49E6EAB-F713-46FB-9AAC-733E952E43C5 Q33952292-7017E8E7-6A1A-4667-93BC-A1146B462227 Q33986960-EDF1BD88-44A7-403D-A67D-60FF0A33C980 Q34367709-5B08C780-BCA8-429C-845F-2115E4E785A3 Q34460622-3281E1E6-79A2-47D7-808C-4923467AAC18 Q34530440-2D66F284-C40C-4F4A-A1B4-DB1B7C4BFC46 Q34575065-A6EE6BEF-D93F-4F40-BDEF-1314A6410F7F Q34635933-218E6F37-8F28-41E5-9548-0F80EFB9A9AA Q34652565-9CEF65C1-2176-4E4D-BF1A-0C26C782E2C9 Q34772547-CD79F3CF-9A53-406C-9F3B-D30AD940B257 Q35296572-407C9869-724B-457F-BA33-C7B621C4BF92 Q35321526-9FFEBDD4-6DF2-4F30-874E-2B2934F7A13B Q35553110-C7EF9F0C-A9D1-46DE-896D-A2474F58330A Q35554779-E97A0E7B-6254-4049-B3D9-B29668F21ACF Q35555003-06C6A8A5-7DE7-496E-8F71-3B7848AE161A Q35637379-EECAB861-57FD-4C5D-9231-4AB6AB0BBD7B Q35674804-F613ED98-71CC-42F9-BC97-31771568CDAC Q35722457-5BFEDA50-AE0D-4B70-A5CE-2608F9CB9718 Q35840775-49FA6BB3-8CBF-4FC0-B227-E35B91F7CB77 Q35866300-6BB901B8-6439-46CF-AC3F-6CC33EAF79E2 Q35934700-56DAC70D-9C9D-43C1-98DE-01B74D910A80

P2860

Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value

http://www.wikidata.org/entity/Q24806041

description

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@ast

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@en

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@nl

type

label

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@ast

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@en

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@nl

prefLabel

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@ast

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@en

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@nl

P1433

Q24806041-202A3A25-340B-4D3F-B9E6-95D9DA1131C0

Q24806041-2974CE38-2AE9-43F2-812E-9C3BB5B7FB24

P1476

Q24806041-303C0F00-237B-4223-A764-F66DE4F1CA18

P2093

Q24806041-3363EC31-BADE-42F9-9B71-D736DB6F6387

Q24806041-66F15994-1BD3-4A2E-8685-E1C57E0D9DD6

Q24806041-682FE907-1357-4364-AA8F-3AFC62064781

Q24806041-84712FBB-B616-462B-89E2-95A869F3A046

P2860

Q24806041-024321D5-EEB3-4740-99B6-AFFA6B0C9CAB

Q24806041-0675BB28-285A-4F8C-8E9B-328FDE6372F9

Q24806041-0C9260A8-CA56-4F02-AD19-E14C3A570204

Q24806041-12937897-1BFA-4926-B3F4-83A45709210D

Q24806041-19F00469-360A-4B3C-88B9-53908689F305

Q24806041-1D12A909-8B83-4CA9-86EA-D1752319DA8D

Q24806041-21FF090F-0F15-4AEC-9EEB-AD37AF53858D

Q24806041-2252FE68-B7AD-4A48-B504-138C9C8705B6

Q24806041-24CB22F0-F0AA-4CDE-8D94-7F583A1A66BD

Q24806041-2E920750-4DAE-4C48-A0A6-B32DE0AA7404

P2888

Q24806041-C9321CF3-1684-409D-BFA8-314C467BBA04

P304

Q24806041-13EAF047-25B3-41F8-96F1-B56FAC75ED10

P31

Q24806041-1CA9EE07-724C-4BA8-9C78-DF377C2CA7AB

Q24806041-DE53E713-8A2A-4F30-96F2-D73827B48D78

P3181

Q24806041-A54AEE22-2AF1-42A3-842D-6DB59422C922

P356

Q24806041-6A5D233C-1C92-494C-BC6D-7E3F9B563171

P407

Q24806041-E80768AC-D003-4920-A921-EE1DAACBDBA3

P433

Q24806041-84BFD2B1-BC9C-415B-BD8D-F2C98BABA124

P478

Q24806041-EF8B9355-B1B1-4FC8-8C60-08737983FEAA

P577

Q24806041-486F14CF-8971-4090-AAD0-308107FCC266

Q24806041-57EF4E80-7FBB-4CBC-8084-805CB3A8FCEB

P5875

Q24806041-253F30B1-FE83-4A01-AF78-B18F9B128A90

P6179

Q24806041-293632CC-7CE4-4A8C-88DE-A98947626AB4

P698

Q24806041-423CFAED-267B-4625-83D9-EA1FF592BEAC

P921

Q24806041-6977F05F-82BC-4A9E-B845-F052CCC0F201

Q24806041-9A3A3C95-733D-4AB3-BCEB-84F78897CBB2

Q24806041-B633CD7E-1F3A-4D80-8C7F-7293F71F6D31

Q24806041-D4CCFA6A-9A53-47B2-8AA8-D55F258C52CB

Q24806041-e3f44626-4c90-4fce-b358-b96781f88653

P932

Q24806041-4E9E92CE-F4B5-4D52-A03A-70EA99B006CF

P3181

P356

P1433

Arthritis Research and Therapy

Arthritis Research

P1476

Autoantibody systems in rheuma ...... nsitivity and diagnostic value

@en

P2093

Erik R Vossenaar

http://www.w3.org/2001/XMLSchema#string

Frank H J van den Hoogen

http://www.w3.org/2001/XMLSchema#string

Martinus A M van Boekel

http://www.w3.org/2001/XMLSchema#string

Walther J van Venrooij

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases

Complete amino acid sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera

Anti-keratin antibodies in rheumatoid arthritis

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

Insights into rheumatoid arthritis derived from the Sa immune system.

DEMONSTRATION OF A NEW ANTINUCLEAR FOR RHEUMATOID ARTHRITIS ANTIBODY (ANTI-RA33) THAT IS HIGHLY SPECIFIC

The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis

P2888

P304

87-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1089321

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/AR395

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11482448

http://www.w3.org/2001/XMLSchema#string

P6179

1052997260

http://www.w3.org/2001/XMLSchema#string

P698

11879544

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

P932

128920

http://www.w3.org/2001/XMLSchema#string